A proposed mechanism of tamoxifen in breast cancer prevention
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference37 articles.
1. A new antiestrogenic agent in late breast cancer. An early appraisal of ICI46474;Cole;Br. J. Cancer,1971
2. National Institute of Health Consensus Development Panel. National institutes of health consensus development conference statement: adjuvant therapy for breast cancer. J Natl Cancer Inst 2001;93:979–89.
3. Tamoxifen as an antitumor agent: effect on estrogen binding;Jordan;J. Endocrinol.,1976
4. Development of antiestrogens and their use in breast cancer: eighth Cain Memorial Award lecture;Lerner;Cancer Res.,1990
5. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study;Fisher;J. Natl. Cancer Inst.,1998
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mass spectroscopy-based proteomics and metabolomics analysis of triple-positive breast cancer cells treated with tamoxifen and/or trastuzumab;Cancer Chemotherapy and Pharmacology;2022-10-20
2. Perspectives and Advances of Nonthermal Plasma Technology in Cancers;IEEE Transactions on Plasma Science;2022-08
3. Cell line-directed breast cancer research based on glucose metabolism status;Biomedicine & Pharmacotherapy;2022-02
4. Untargeted Metabolomics of Breast Cancer Cells MCF-7 and SkBr3 Treated With Tamoxifen/Trastuzumab;Cancer Genomics - Proteomics;2021-12-23
5. GC–MS based comparative metabolomic analysis of MCF-7 and MDA-MB-231 cancer cells treated with Tamoxifen and/or Paclitaxel;Journal of Proteomics;2020-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3